PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by BridgeBiofor the distribution of Attruby™ (acoramidis), a high-affinity transthyretin...

PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Calliditas Therapeutics for the exclusive distribution of TARPEYO® (budesonide) delayed...

PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it was selected by Upsher-Smith Laboratories, LLC for the distribution of TORPENZ™ (everolimus) Tablets for...

PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it is partnering with Gilead Sciences, Inc. for the distribution of a novel selective peroxisome proliferator-activated...

PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it is partnering with ITF Therapeutics LLC for the U.S. distribution of DUVYZAT™ (givinostat), the first nonsteroidal...

PITTSBURGH – PANTHERx® Rare, one of the nation’s largest and fastest growing rare disease specialty pharmacies, today announced the appointment of Bansi Nagji as CEO effective August 1, 2024. In this role, Mr. Nagji will continue his existing service...